» Articles » PMID: 35875050

Using Machine Learning Methods to Predict Bone Metastases in Breast Infiltrating Ductal Carcinoma Patients

Overview
Specialty Public Health
Date 2022 Jul 25
PMID 35875050
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer (BC) was the most common malignant tumor in women, and breast infiltrating ductal carcinoma (IDC) accounted for about 80% of all BC cases. BC patients who had bone metastases (BM) were more likely to have poor prognosis and bad quality of life, and earlier attention to patients at a high risk of BM was important. This study aimed to develop a predictive model based on machine learning to predict risk of BM in patients with IDC. Six different machine learning algorithms, including Logistic regression (LR), Naive Bayes classifiers (NBC), Decision tree (DT), Random Forest (RF), Gradient Boosting Machine (GBM), and Extreme gradient boosting (XGB), were used to build prediction models. The XGB model offered the best predictive performance among these 6 models in internal and external validation sets (AUC: 0.888, accuracy: 0.803, sensitivity: 0.801, and specificity: 0.837). Finally, an XGB model-based web predictor was developed to predict risk of BM in IDC patients, which may help physicians make personalized clinical decisions and treatment plans for IDC patients.

Citing Articles

Machine learning-based prediction of distant metastasis risk in invasive ductal carcinoma of the breast.

Dong J, Lei R, Ma F, Yu L, Wang L, Xu S PLoS One. 2025; 20(2):e0310410.

PMID: 40009584 PMC: 11864521. DOI: 10.1371/journal.pone.0310410.


Machine learning for predicting neoadjuvant chemotherapy effectiveness using ultrasound radiomics features and routine clinical data of patients with breast cancer.

Zhou P, Qian H, Zhu P, Ben J, Chen G, Chen Q Front Oncol. 2025; 14:1485681.

PMID: 39927116 PMC: 11803464. DOI: 10.3389/fonc.2024.1485681.


Bone scintigraphy based on deep learning model and modified growth optimizer.

Magdy O, Elaziz M, Dahou A, Ewees A, Elgarayhi A, Sallah M Sci Rep. 2024; 14(1):25627.

PMID: 39465262 PMC: 11514163. DOI: 10.1038/s41598-024-73991-8.


Development and validation of an artificial intelligence model for predicting de novo distant bone metastasis in breast cancer: a dual-center study.

Zhang W, Tan Y, Huang Z, Tan Q, Zhang Y, Wei C BMC Womens Health. 2024; 24(1):442.

PMID: 39098907 PMC: 11299401. DOI: 10.1186/s12905-024-03264-z.


Tribulations and future opportunities for artificial intelligence in precision medicine.

Carini C, Seyhan A J Transl Med. 2024; 22(1):411.

PMID: 38702711 PMC: 11069149. DOI: 10.1186/s12967-024-05067-0.


References
1.
Li W, Liu Y, Liu W, Tang Z, Dong S, Li W . Machine Learning-Based Prediction of Lymph Node Metastasis Among Osteosarcoma Patients. Front Oncol. 2022; 12:797103. PMC: 9067126. DOI: 10.3389/fonc.2022.797103. View

2.
Bastanlar Y, Ozuysal M . Introduction to machine learning. Methods Mol Biol. 2013; 1107:105-28. DOI: 10.1007/978-1-62703-748-8_7. View

3.
Wu Q, Li J, Zhu S, Wu J, Chen C, Liu Q . Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study. Oncotarget. 2017; 8(17):27990-27996. PMC: 5438624. DOI: 10.18632/oncotarget.15856. View

4.
Zhao W, Wu L, Zhao A, Zhang M, Tian Q, Shen Y . A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study. BMC Cancer. 2020; 20(1):982. PMC: 7549197. DOI: 10.1186/s12885-020-07449-1. View

5.
Chen M, Sun H, Zhao Y, Fu W, Yang L, Gao S . Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis. Sci Rep. 2017; 7(1):9254. PMC: 5569011. DOI: 10.1038/s41598-017-10166-8. View